OrBec FDA Approval Status
FDA Approved: No
Brand name: orBec
Generic name: beclomethasone dipropionate
Company: DOR BioPharma, Inc.
Treatment for: Intestinal Graft-versus-Host Disease (iGVHD)
orBec (oral beclomethasone dipropionate), is a potent, locally-acting corticosteroid being developed for the treatment of for the treatment of gastrointestinal graft-versus-host disease.
Development timeline for orBec
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.